Amundi Axonics, Inc. Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Axonics, Inc. stock. As of the latest transaction made, Amundi holds 94,596 shares of AXNX stock, worth $6.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,596

Previous 125,380 24.55%

Holding current value

$6.71 Million

Previous $8.43 Million 21.82%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$67.3 - $69.67 $2.07 Million - $2.14 Million	-30,784 Reduced 24.55%	94,596 $6.59 Million
Q2 2024 Aug 14, 2024	SELL	$66.47 - $69.65 $34.2 Million - $35.9 Million	-514,985 Reduced 80.42%	125,380 $8.43 Million
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $2.55 Million - $3.12 Million	-44,960 Reduced 6.56%	640,365 $44.2 Million
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $720,552 - $930,240	-14,592 Reduced 2.08%	685,325 $42.6 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $298,503 - $383,623	6,137 Added 0.88%	699,917 $39.3 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $1.16 Million - $1.46 Million	24,175 Added 3.61%	693,780 $35 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $6.31 Million - $8.08 Million	120,018 Added 21.84%	669,605 $36.5 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $10.4 Million - $13.4 Million	175,387 Added 46.87%	549,587 $34.4 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $4.53 Million - $6.11 Million	-78,203 Reduced 17.29%	374,200 $28.7 Million
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $869,711 - $1.42 Million	-22,018 Reduced 4.64%	452,403 $28.3 Million
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $320,089 - $459,277	-7,318 Reduced 1.52%	474,421 $30.4 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $6.69 Million - $9.81 Million	133,741 Added 38.43%	481,739 $26.5 Million
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $1.15 Million - $1.53 Million	19,480 Added 5.93%	347,998 $22.7 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $16.9 Million - $22 Million	328,518 New	328,518 $20.8 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account